Investors

Financials & Filings

Document Details

Filing Date
Feb 16, 2016
Document Date
Feb 16, 2016
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals